Mar 19, 2021
ALAMEDA, Calif. March, 18, 2021–Astra Space Inc. (“Astra”), the fastest privately-funded company in history to demonstrate orbital launch capability, today announced that Chris Kemp, co-founder and CEO, will participate in the BofA Securities Space, Transportation, Aviation, and Autos Research
Mar 12, 2021
ALAMEDA, Calif.–Astra Space Inc. (“Astra”), the fastest privately-funded company in history to demonstrate orbital launch capability, today announced that Chris Kemp, co-founder and CEO, will participate in the Roth Capital Partners 33rd Annual Growth Stock Conference. Astra and Holicity Inc.
Mar 05, 2021
ALAMEDA, Calif. — Astra Space Inc. (“Astra”), the fastest privately-funded company in history to demonstrate orbital launch capability, today announced that Chris Kemp, co-founder and CEO, will participate in two upcoming investor events. Astra and Holicity Inc.
Feb 02, 2021
BlackRock-managed funds and accounts lead investment in Astra to launch a new generation of space services to improve life on Earth ALAMEDA, Calif., February 2, 2021 – Astra, the fastest privately-funded company in history to demonstrate orbital launch capability, and Holicity Inc.
Dec 30, 2019
*** This is a test sample for BUSINESS WIRE quarterly results release style. It will need to be removed before the site is set to live. *** Revenues of $4.7 billion Free cash flow of $0.6 billion GAAP diluted loss per share of $0.24 Non-GAAP diluted EPS of $0.78 Restructuring plan on-track to
Dec 13, 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras porta, sapien a molestie rhoncus, odio lorem volutpat leo, at sollicitudin nisi lacus et quam. Morbi dignissim, magna vitae posuere semper, libero dolor pharetra diam, id venenatis nulla libero sed nibh. Etiam eu sapien odio.
Dec 12, 2019
*** This is a test sample for GLOBE NEWSWIRE quarterly results release style. It will need to be removed before the site is set to live. *** Second quarter revenue increased to $11.6 million compared to $4.6 million in the same period last year. Received a strategic investment of $100 million from
Dec 03, 2019
*** This is a test sample for PRNewswire quarterly results release style. It will need to be removed before the site is set to live. *** DIVISIONR (valbenazine) Second Quarter Net Product Sales of $96.9 Million with Approximately 16,700 TRx DIVISION? (elagolix), the First FDA-Approved Oral